High ghrelin levels in post-treatment euthyroid patients with Hashimoto's thyroiditis: a case-control preliminary...

Area of Science:

• Endocrinology
• Immunology
• Metabolic Research

Background:

• Hashimoto's thyroiditis is a chronic autoimmune condition affecting the thyroid gland.
• Ghrelin, a peptide hormone, plays a key role in appetite regulation and has been implicated in inflammatory processes.
• Existing research on ghrelin levels in Hashimoto's thyroiditis patients presents conflicting findings.

Purpose of the Study:

• To investigate the relationship between thyroid status and plasma ghrelin levels in euthyroid female patients with Hashimoto's thyroiditis.
• To compare ghrelin levels in treated Hashimoto's patients with healthy controls.
• To explore potential links between ghrelin and metabolic parameters in this patient group.

Main Methods:

• A case-control study involving 25 euthyroid female patients with Hashimoto's thyroiditis and 25 healthy female controls.
• Participants were assessed after at least 2 months of normalized thyroid hormones and body weight with L-thyroxine replacement.
• Measurements included plasma ghrelin, thyroid hormones, thyroid autoantibodies, and metabolic parameters (BMI, fat mass, HDL cholesterol).

Main Results:

• Plasma ghrelin levels were significantly elevated in patients with Hashimoto's thyroiditis compared to healthy controls (p<0.001).
• No significant differences were observed in body mass index, fat mass, fat-free mass, or high-density lipoprotein cholesterol between the two groups.

Conclusions:

• The study provides evidence supporting a state of hyperghrelinemia in euthyroid patients with Hashimoto's thyroiditis, even after treatment.
• Elevated ghrelin levels in Hashimoto's patients may be independent of thyroid hormone status and metabolic changes.
• Further research is warranted to understand the implications of hyperghrelinemia in Hashimoto's thyroiditis.